Get the latest tech news

The FDA just cleared this app to treat depression (and it's not talk therapy)

Rejoyn is now available to the public.

"EMFT is designed to really enhance circuits that have been shown to be not optimally functioning in depression," Dr. John Kraus, Otsuka Pharmaceutical's chief medical officer, told Mashable. When the six-week treatment period ends, patients can access the cognitive behavioral therapy lessons for another four weeks. "Pure self-help is hard, but at least having your clinician check in...[and] keeping you accountable is going to be very important for making it work," Torous said.

Get the Android app